Enyedy Mark J

Avg. Two Year Performance

241% Avg. Purchase Return
85% Compound
36% Avg. Sale Return
17% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return3%31%128%206%241%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return(< 1%)3%19%36%36%
Sale Success Rate1 of 21 of 22 of 21 of 21 of 2
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 2.18K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 31.14K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--